Progress in the diagnosis and treatment of paraganglioma

4Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Neuroendocrine tumors derived from the adrenal medulla and the adrenal gland are called pheochromocytoma (PHEO) and paraganglioma (PGL), respectively. PGLs are neuroepithelial cell clusters associated with sympathetic or parasympathetic nerves, and are scattered throughout the body. According to the World Health Organization, the presence of distant metastases indicates malignant PGL. Most PGLs are benign, but their high secretion of catecholamines in the blood is associated with high blood pressure, cardiovascular disease, and death. Further research on PGL is required to provide a theoretical basis for clinical diagnosis and treatment. This article reviews the genetics, clinical manifestations, benign and malignant forms, current major diagnostic methods, and progress in the treatment of PGL.

Cite

CITATION STYLE

APA

Wang, B., & Qiu, J. (2019). Progress in the diagnosis and treatment of paraganglioma. Translational Cancer Research. AME Publishing Company. https://doi.org/10.21037/tcr.2019.10.11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free